Efficacy and Safety of DWJ1248 With Remdesivir in Severe COVID-19 Patients

NCT04713176 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

240

Enrollment

INDUSTRY

Sponsor class

Stopped Termination of study due to sponsor's internal decision

Conditions

Severe COVID-19

Interventions

DRUG: DWJ1248 with Remdesivir
DRUG: Placebo with Remdesivir

Sponsor

Daewoong Pharmaceutical Co. LTD.